Chimera Investment Corporation Announces
Pricing of Public Offering of Common Stock
April 01, 2010 09:18 AM Eastern Daylight Time
NEW YORK--(EON: Enhanced Online News)--Chimera Investment Corporation (NYSE: CIM) today announced
the pricing of an underwritten public offering of 85 million shares of its common stock for expected net proceeds of
approximately $307 million before expenses.
Chimera has also granted the underwriter a 30-day option to purchase up to an additional 12,750,000 shares of
common stock solely to cover over-allotments. Chimera expects to use the proceeds of this offering to finance the
acquisition of residential mortgage-backed securities (RMBS) not guaranteed by a U.S. government agency, RMBS
guaranteed by a U.S. government agency, prime and Alt-A mortgage loans, commercial mortgage-backed
securities, collateralized debt obligations, and other consumer or non-consumer asset-backed securities. Chimera
may also use the proceeds for other general corporate purposes such as repayment of outstanding indebtedness,
working capital and for liquidity needs.
Credit Suisse Securities (USA) LLC is acting as the sole underwriter for the offering.
Chimera has filed a shelf registration statement and prospectus with the Securities and Exchange Commission (SEC),
and will file a prospectus supplement for the offering to which this communication relates. Before you invest, you
should read the prospectus supplement and the accompanying prospectus and other documents Chimera has filed
with the SEC for more complete information about Chimera and this offering. You may obtain these documents for
free by visiting EDGAR on the SEC Web site at http://www.sec.gov. Alternatively, Chimera, the underwriter or any
dealer participating in the offering will arrange to send you the prospectus supplement and accompanying prospectus
if you request them by contacting:
This press release shall not constitute an offer to sell or a solicitation of an offer to buy the shares. An offering of the